SANM
$149.64 at the check
LONG

Kairon's answer on SANM: not yet.

Leaning up, but not enough conviction for a trade.

Checked Nov 10, 2026 at $149.64, time frame 3-6 months, confidence high
Why? For, against, what would change it
  • ForSANM is priced at a substantial discount to its expected growth.
  • AgainstExtremely low net margin signals weak operational buffer.
Result check on May 9, 2027: open.

The 10-second check

Loading filings…

Both sides

More for

The company’s operational execution is consistently exceeding market expectations.

The company is actively returning capital to shareholders through buybacks, reducing dilution and enhancing future EPS.

More against

The systematic strategy basket is overwhelmingly bearish, including trend, volatility, and quality factors; regime is "risk-off," and historical performance in this regime is negative.

Absent sector/peer benchmarking, the "cheap growth" optics may hide structural underperformance or risk of value trap.

Read the full debate between the bull and the bear analyst

Bull Analyst: BULL CASE ARGUMENTS

---

Argument 1 – Valuation Relative to Growth [HIGH conviction]
Evidence: Forward P/E: 8.25x (Fundamentals Report); PEG ratio: 0.46; next year revenue growth estimate: +16% y/y; forward EPS estimate revision: +3.4% in past 90 days (from $15.7 to $16.24); price/book: 2.87x.
Thesis: SANM is priced at a substantial discount to its expected growth. A forward P/E well below 10x, combined with a PEG ratio under 0.5 and 16% revenue growth, signals market skepticism is over-discounting risks. With consistent upward EPS estimate revisions and book value modestly priced, the risk/reward on valuation is strongly positive.

---

Argument 2 – Earnings Momentum & Beat Streak [HIGH conviction]
Evidence: Last four quarters: earnings surprises of +11%, +32%, +19%, +36% vs consensus; FY+1 EPS estimate up 3.4% in past 90 days.
Thesis: The company’s operational execution is consistently exceeding market expectations. Sustained double-digit beats indicate management guidance is conservative and the business is able to deliver upside amid macro and sector volatility. This track record increases the probability of further estimate revisions and supports forward multiples.

---

Argument 3 – Capital Return Discipline [MEDIUM conviction]
Evidence: Share count declined -5.7% over three years (buybacks); ROE at 15.1%.
Thesis: The company is actively returning capital to shareholders through buybacks, reducing dilution and enhancing future EPS. ROE above 15% demonstrates effective deployment of equity and suggests management is prioritizing shareholder value even in a low-margin environment (offsetting intrinsic profitability concerns).

---

Argument 4 – Technical Regime & Trend Alignment [MEDIUM conviction]
Evidence: Price +26.6% above 200MA ($83.27 vs $65.77); +21.2% above 50SMA ($68.68); MACD bullish; volume spikes confirm upmoves; SPY in BULL regime (+11.9% above 200MA).
Thesis: SANM is in a strong technical uptrend, confirmed by both moving averages and momentum indicators. Volume supports the trend, and the broader market is aligned in a bull regime. While RSI is overbought, price strength and trend persistence indicate sustained institutional accumulation. Pullbacks may occur, but trend-following setups remain favorable provided risk is managed.

---

Argument 5 – Free Cash Flow Turnaround [MEDIUM conviction]
Evidence: TTM FCF was negative at ($355.5M), but most recent year swung positive: $473M FCF in 2025.
Thesis: The company's ability to generate positive free cash flow after a weak prior period demonstrates operational flexibility and risk mitigation. This turnaround lowers funding and liquidity risk, especially given a healthy current ratio (1.62). Confirmation of continued FCF improvement would further increase conviction, but the latest numbers point toward stabilization.

---

BEAR COUNTER-ARGUMENTS

---

Bear said: "Net margin is just 2.6% – low absolute profitability and operational leverage risk if input costs or demand weaken."
Counter: While net margin is low (2.6%), the company has demonstrated positive operating margin (8.21%) and high ROE (15.1%). The buyback program (-5.7% dilution) and recent FCF swing to +$473M mitigate the impact of margin compression and provide financial flexibility. Additionally, strong earnings beat streaks (+11%, +32%, +19%, +36%) evidence resilient execution in spite of macro risk.

---

Bear said: "Free cash flow is inconsistent, negative TTM despite 2025 positives—the trend needs confirmation."
Counter: TTM FCF was indeed negative, but latest full-year FCF was $473M positive. Current ratio 1.62 reflects sound liquidity, and debt/equity 74.7% is below sector average, minimizing solvency risk should operational volatility continue. A positive FCF in the most recent period, combined with rising future revenue/EPS estimates, suggests the FCF trajectory is improving.

---

Bear said: "Analyst price target dispersion is wide (36% of mean)—signal is uncertain, risk of value trap or coming reset."
Counter: Although price targets scatter widely, the mean is $249 (66% upside from current $149.6), and recent estimate revisions are rising (EPS +3.4% in 90 days). The wide dispersion points to uncertainty, but forward valuation multiples (PE 8.25x, PEG 0.46) and recent operational outperformance reduce the probability of a value trap. Ongoing earnings beats indicate upside surprise potential.

---

Bear said: "Sector/peer context missing—cannot confirm these scores are above peer median."
Counter: Absence of direct peer metrics is a limitation, but with valuation multiples (forward PE, PEG, price/book) at levels historically considered attractive for growth and profitability metrics (ROE 15.1%), the risk of material sector lag is reduced. The strong buyback trend and operational beats provide evidence of management execution regardless of peer context.

---

BULL THESIS INVALIDATION LEVEL

The bull thesis breaks if:
- Stock closes below the 10EMA ($76.46), invalidating the trend and signaling momentum exhaustion and/or regime change.
- Next earnings show revenue growth <10% y/y and miss EPS consensus by >10% (ending the positive surprise streak and indicating breakdown in growth).
- FCF returns negative in next fiscal report (loss of turnaround credibility).

---

OVERALL BULL CONVICTION: MEDIUM (6.5/10)

Justification:
- Two arguments have HIGH conviction (valuation/growth and earnings momentum) from clear numerical evidence.
- Three arguments are MEDIUM conviction (capital returns, technical alignment, FCF turnaround) due to risk factors and partial signal conflicts.
- Market/technical regime is supportive, but quant signal conflicts (trend-following negative, mean-reversion positive) and missing sector RS lower conviction.
- FCF stabilization and sector leadership confirmation would elevate conviction; current state justifies strong medium bull stance but not outright high, given data quality and regime overlays.
Bear Analyst: ## BEAR CASE RISKS

---

Risk 1 – Technical: Mean-Reversion & Overextension [HIGH conviction]
Evidence: RSI at 79.97 (extreme overbought); price is +26.6% above 200MA ($83.27 vs $65.77), +21.2% above 50SMA. Relative Strength tool error—no confirmation sector leadership. Quant regime P(bull) = 0.00, composite quant score -23.7/100; recent max drawdown -53.94%, current drawdown -47.07%.
Risk: The stock is deeply overbought by all major measures, with technicals primed for mean-reversion rather than further upside. Quant regime, trend, and risk signals are strongly bearish. Overextension unsupported by sector RS or strong price/volume factors increases vulnerability to sharp correction.
Quantified downside: A mean-reversion to the 50SMA ($68.68)—normal in elevated volatility regimes—would represent a -17.5% decline from current price. In case of quant trend/volatility normalization (move to 200MA: $65.77), -21.0% downside.

---

Risk 2 – Profitability: Ultra-Low Margins – Vulnerability to Shock [HIGH conviction]
Evidence: Net margin 2.6%, Op margin 8.21% (low for hardware/EMS sector); FCF negative ($355.5M) TTM; last year positive FCF ($473M) is a one-off so far, inconsistent FCF history. If gross margin compresses 200bps (e.g. input cost inflation), net margin could turn negative.
Risk: Extremely low net margin signals weak operational buffer. Even modest cost or demand shocks could erase profitability. FCF instability (only 1 year positive) means reliance on upcycle, not proven resilience.
Quantified downside: Re-rating from forward P/E 8.25x to 12x trailing due to reset in profitability (loss year), could drive price from $83.27 to $55-60 (comparable to recent drawdown lows)—-30% to -35% downside.

---

Risk 3 – Quant/Regime: All Major Trend and Quality Signals Negative, High Volatility [MEDIUM conviction]
Evidence: Quant composite -23.7/100 (bearish); trend-following and quality signals <-70 across the board; realized ann. vol 96.7% (beta 1.30, current drawdown -47%). Sharpe over last 6 months: -1.35.
Risk: The systematic strategy basket is overwhelmingly bearish, including trend, volatility, and quality factors; regime is "risk-off," and historical performance in this regime is negative. Sharpe and Sortino both negative. If market volatility spikes or regime worsens, the stock's high beta will amplify downside.
Quantified downside: With beta 1.3, and market correction of 10%, SANM could fall 13-16% (to $70-72), not even counting idiosyncratic drawdown risk.

---

Risk 4 – Peer/Estimate Quality: High Price Target Dispersion & No Sector/Peer Benchmark [LOW conviction]
Evidence: Analyst price targets range $210–300, mean $249, yet 36% dispersion (wide). Fund scores cite "no evidence to adjust for sector context." Recent revenue/EPS beats, but without peer context, may lag sector upcycle.
Risk: Absent sector/peer benchmarking, the "cheap growth" optics may hide structural underperformance or risk of value trap. Wide analyst dispersion = weak consensus.
Quantified downside: If market re-rates to sector median (unknown, but typical Fwd PE/PEG for sector = 12–15x/0.8–1.1), SANM rerates to $55–$65 (-22% to -34%).

---

Risk 5 – Insider/Smart Money: No Insider Buying, One Sale [LOW conviction]
Evidence: Zero insider purchases in last 90 days; 1 sale ($24K); Kairon: after 671 similar purchase signals, the stock underperformed in 62.6% of cases (mean -5.04%).
Risk: Lack of insider conviction signals no "real money" belief in the upside, especially relevant with share price extended.
Quantified downside: Not a direct catalyst, but increases probability of retracement by 5–7% vs. market, based on Kairon excess return analysis.

---

## BULL COUNTER-ARGUMENTS

---

Bull said: *Valuation is at a large discount to expected growth: Fwd PE 8.25x, PEG 0.46, revenue growth +16% y/y, EPS rising 3.4%.*
- Counter: Current net margin is only 2.6%, and TTM FCF remains negative ($355.5M)—implying the "E" in PE is low quality and susceptible to cyclical risk. PEG is only valid if growth persists AND converts to cash. Quant scores disagree with market narrative (composite -23.7/100). If revenue growth slows to sector average or margin compresses 150bps (likely in slowdown), fair PE is 12–15x trailing, and DCF implied upside evaporates.

---

Bull said: *Sustained earnings beats: +11%, +32%, +19%, +36% last 4 quarters, with estimate revisions up 3.4%.*
- Counter: Earnings beats came in the context of a "bull" market regime (SPY +11.9% above 200MA). Quant's HMM regime probability for bull is 0.00, with -47% current drawdown (already pricing in prior outperformance). Beat streaks in hardware/EMS are often cyclical—last year positive FCF could be mean-reverting, not structural improvement.

---

Bull said: *Capital return via buybacks (-5.7% dilution last 3y), ROE 15.1%.*
- Counter: Buybacks are only value-accretive if funded from sustainable cash generation, not from balance sheet stretch. FCF negative TTM, only recently positive, while net margin is still just 2.6%. Organic capital return should be higher priority than buybacks in this FCF context.

---

Bull said: *Strong technical uptrend (+26.6% above 200MA, MACD bullish, strong volume).*
- Counter: The technicals are at extreme overbought (RSI 79.97), with no sector RS confirmation (tool error). Quant trend-following signals are max negative (-87 trend, -74 slope), composite regime is MEAN-REVERTING, not momentum/trend. Historically, such positioning leads to acute downside moves (last drawdown: -53.9%).

---

Bull said: *Recent positive FCF ($473M) marks a turnaround, now liquid (current ratio 1.62).*
- Counter: FCF streak is not yet established—TTM still negative $355.5M, only one positive year amid broad cyclical upturn. Absent 2–3 consecutive positive FCF years, there's a significant risk it's a one-off. Current ratio is fine now, but in prior downturns, liquidity deteriorated rapidly (see negative FCF swing).

---

## RED FLAGS FROM ANALYST REPORTS

- Net margin 2.6% – unusually low for this revenue base; little shock absorption.
- FCF negative TTM ($355.5M), with only one (latest) positive year—trend not yet confirmed.
- Analyst price target dispersion 36% of mean—consensus is shaky, increases risk of sharp re-rating.
- Sector/peer context missing—cannot confirm if SANM is outperforming in sustainability, margins, or valuation; the "cheap" multiples may mask quality.
- Market leadership unconfirmed – Relative Strength tool error = sector lag is possible, not verified.

## BEAR THESIS CONFIRMATION SIGNAL

Bear case accelerates if:
- SANM closes below the 50SMA ($68.68)—historically, this triggers further technical liquidation (would confirm >-17% mean-reversion already underway).
- Next quarter: Net margin falls below 2.0% or FCF is negative again—structural profitability concern confirmed.
- SPY regime flips <200MA or volatility spikes (realized vol >120%)—SANM, with beta 1.3, will likely outperform the index on the downside.

## OVERALL BEAR CONVICTION: HIGH (8/10)

### Justification:
- Two HIGH conviction risks: (1) technical/mean-reversion signals (all major factors negative, price overextension + lack of sector confirmation); (2) ultra-low margin, high operational leverage.
- Multiple MEDIUM risks: Quant/vol/risk regime is risk-off, high volatility; lack of clear sector benchmarking and smart money/institutional support; FCF inconsistency.
- Fundamental and quant red flags outnumber positives—current uptrend has failed trend-following quant test, and regime is mean-reverting.
- Missing sector RS and only one year of positive FCF make this a shaky up-cycle rally, not a confirmed turnaround.
- Market regime supportive (bull), but SANM-specific signals are overwhelmingly cautionary.

### Downside:
If these risks materialize, a reversion to technical and fundamental means targets -17% to -35% downside ($55–68), in-line with volatility regime, prior drawdowns, and normalized valuation assumptions.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on SANM

1 past checks: 1 directional calls (0 right, 1 wrong). Measured by price since each check, no costs. How we measure. Every 'not now' answer.

Nov 10, 2026: Long at $149.64, −6.6 % sincewrong

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Support$76.46
Resistance$86.05
Horizon3-6 months
Quant score-24/100

Executive summary

No trade is recommended for SANM at current price levels due to a structurally insufficient risk/reward ratio (0.4:1 vs minimum 2:1), technical exhaustion signals (RSI near 80, price above upper Bollinger band), and missing sector relative strength. Bullish market regime and strong fundamental profile cannot override core technical entry risks. Multiple risk managers and quant analysis confirm a negative expected value with Kelly criterion producing 0% allocation. Capital preservation mandates discipline; setup fails best practice and mandates a PASS.

Investment thesis

Analyst and risk manager consensus is clear: SANM offers strong trend and positive regime alignment, but entry at $83.27 yields an upside target ($86.05, +3.3%) well below the defensible stop-loss ($76.46, -8.2%), making R/R grossly insufficient (~0.4:1). Mean-reversion risk is elevated (RSI 79.97), and technical history shows frequent 4%+ pullbacks from similar conditions. Quant signals are heavily bearish despite pockets of momentum, with regime, trend, and risk-following indicators aligned against chase-long entries. Sector leadership signal is missing, further lowering confidence and increasing risk of stop-out. All lessons and rules point toward no position until a pullback restores signal structure.

Valuation assessment

SANM trades at $83.27, materially above all major moving averages (200SMA, 50SMA, 10EMA). Momentum is strong, but technical extension, elevated realized volatility (ATR: 3.2%), and drawdown history (-54% 1y max) skew near-term risk/reward sharply negative. Fundamental profile offers value, but current technical setup cannot justify a new entry.

Scenario analysis

Bull scenario: trend continues, retest prior swing high at $86.05 (+3.3%), but no credible technical evidence for further upside before pullback; mean-reversion risk is high. Base bear scenario: price corrects to 10EMA ($76.46, -8.2%). Max bear: full unwind to 50SMA ($68.68). EV is negative in weighted probabilities; all outcomes fail minimum risk/reward criteria.

Key risks

High risk of mean-reversion from overextended price; missing sector RS confirmation increases the probability of rapid pullbacks; technical regime strongly advises against bullish exposure despite broad market strength. Quant risk signals reinforce downside bias.

AI-generated. Created 2026-11-10 13:28 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $149.64. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure. Every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum Privacy Terms Disclaimer